Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Phase 4

Terminated

• Conditions: Alzheimer's Disease
• Interventions: Drug: DONEPEZIL HYDROCHLORIDE

• Registration Number: NCT00165750
• Lead Sponsor: Eisai Korea Inc.

Brief Summary

This study investigate the relationship between regional brain volume measured by MRI and donepezil treatment response in patients with Alzheimer's Disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-03
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-14
• Primary Completion: 2008-08
• Study Completion: 2008-11
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-19
• Last Update Posted: 2013-11-20

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	DONEPEZIL HYDROCHLORIDE	-

Primary Outcome Measures

Name	Time	Method
MRI, ADAS-cog	0, 12, 24 weeks

Secondary Outcome Measures

Name	Time	Method
ADL, BPSD, CDR-SB, ZBI, GHQ, CIBIC plus	0, 12, 24 weeks

Trial Locations

Locations (1)

Cheonnam University Hospital; 🇰🇷 Gwangju, Korea, Republic of